Skip to Content
News & Insights

Category: Legal Updates

It has been nearly six months since the EPO updated the Guidelines for Examination at the European Patent Office (“the Guidelines”).   We take a look […]

READ MORE

Supplementary protection certificates (SPCs) allow for up to five and half years of additional patent protection for a medicinal product that has been authorised to […]

READ MORE

With the passing of the Trademark Modernization Act of 2020 (TMA), trademark stakeholders will need to familiarize themselves with changes to the Lanham Act, as […]

READ MORE

The end of the BREXIT transition period has no effect on European patents or patent applications. The European Patent Office (EPO) is European in name […]

READ MORE

A number of IP rights that apply across the European Union no longer apply to the United Kingdom, now that it has left the EU […]

READ MORE

A number of IP rights that apply across the European Union no longer apply to the United Kingdom, now that it has left the EU […]

READ MORE

RIP CBM Review?

Sep 22, 2020 | General

The Leahy-Smith America Invents Act (“AIA”) created three new procedures to be presided over by the newly created Patent Trial and Appeal Board (“PTAB”).  Two […]

READ MORE

While the early hypothesis that chimeric antigen receptors (CARs) could be expressed in T-cells (CAR T-cells) for use as therapeutic agents was more than three […]

READ MORE

With the passage of the America Invents Act (AIA), the U.S. moved from a First-To-Invent system to a First-Inventor-To-File system in order to harmonize the […]

READ MORE